Clinical Trial Update: Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis [NA]

View source ↗

Summary

A completed clinical trial investigating topical 0.15% ganciclovir gel for CMV anterior segment infection presenting as anterior uveitis and CMV endotheliitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis
• Cytomegalovirus Anterior Segment Infection
• Cytomegalovirus Endotheliitis

Drugs mentioned

• Ganciclovir ophthalmic gel 0.15% (Ganciclovir)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Cytomegalovirus Anterior Segment Infection, Anterior Uveitis | NA | Status: COMPLETED